NCT02281474View on ClinicalTrials.gov

Nilotinib in Cognitively Impaired Parkinson Disease Patients 001

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2015

Conditions
Parkinson's DiseaseParkinson's Disease DementiaDiffuse Lewy Body Disease
Interventions
DRUG

Nilotinib

Trial Locations (1)

20007

MedStar Georgetown University Hospital, Washington D.C.

All Listed Sponsors
lead

Georgetown University

OTHER

NCT02281474 - Nilotinib in Cognitively Impaired Parkinson Disease Patients 001 | Biotech Hunter | Biotech Hunter